Bg pattern

ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

EndolucinBeta 40 GBq/ml Radiopharmaceutical Precursor in Solution

Lutetium Chloride (177Lu)

This medicinal product is subject to additional monitoring. This will allow for the quick identification of new safety information. You can help by reporting any side effects you may experience. The last section of section 4 will provide information on how to report side effects.

Read all of this leaflet carefully before you start receiving the medicinal product combined with EndolucinBeta, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your nuclear medicine doctor who will be supervising the procedure.
  • If you experience side effects, consult your nuclear medicine doctor. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is EndolucinBeta and what is it used for
  2. What you need to know before you are given the radiolabelled medicinal product with EndolucinBeta
  3. How to use the radiolabelled medicinal product with EndolucinBeta
  4. Possible side effects
  1. Storage of EndolucinBeta
  2. Package Contents and Further Information

1. What is EndolucinBeta and what is it used for

EndolucinBeta is not the final medicinal product and must not be used on its own. It must be used in combination with another medicinal product (carrier medicinal product).

EndolucinBeta is a type of product known as a radiopharmaceutical precursor. It contains the active substance lutetium chloride (177Lu) which emits beta radiation, allowing for a localized radiation effect. This radiation is used to treat certain diseases.

EndolucinBeta must be combined with a carrier medicinal product in a process known as radiolabelling before administration. The carrier medicinal product then takes EndolucinBeta to the site in the body where the disease is located.

These carrier medicinal products have been specifically developed for use with lutetium chloride (177Lu) and may be substances designed to recognize a specific type of cell in the body.

Administration of radiolabelled medicinal products with EndolucinBeta involves exposure to radioactivity. Your doctor and nuclear medicine doctor have considered that the clinical benefit you will receive from the procedure with the radiopharmaceutical outweighs the risks of radiation.

Refer to the package leaflet of the medicinal product that will be radiolabelled with EndolucinBeta.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given the radiolabelled medicinal product with EndolucinBeta

The radiolabelled medicinal product with EndolucinBeta must not be used

  • if you are allergic to lutetium chloride (177Lu) or any of the other ingredients of this medicinal product (listed in section 6).
  • if you are pregnant or think you may be pregnant.

Refer to the package leaflet of the medicinal product that will be radiolabelled with EndolucinBeta for more information.

Warnings and Precautions

EndolucinBeta must not be administered directly to patients.

Be particularly careful with the radiolabelled medicinal product with EndolucinBeta:

  • if you have kidney problems or bone marrow disease.

Treatment with lutetium (177Lu) labelled ligands may cause the following side effects:

  • Reduced red blood cell count (anaemia).
  • Reduced platelet count in the blood (thrombocytopenia), which are important for stopping bleeding.
  • Reduced white blood cell count (leucopenia, lymphopenia or neutropenia), which are important for protecting the body against infections.

Most of these events are mild and transient. In some patients, a reduction in the number of all three types of blood cells (red blood cells, platelets and white blood cells - pancytopenia) has been described, which may require interruption of treatment.

Because lutetium (177Lu) may sometimes affect your blood cells, your doctor will perform blood tests before starting treatment and at regular intervals during treatment. Talk to your doctor if you experience shortness of breath, bruising, nosebleeds, bleeding gums or if you develop a fever.

During peptide receptor radionuclide therapy of neuroendocrine tumours, the kidneys excrete radiolabelled somatostatin analogues. Therefore, your doctor will perform a blood test to measure kidney function before starting treatment and during treatment.

Treatment with lutetium (177Lu) may cause changes in liver function. Your doctor will perform a blood test to monitor your liver function during treatment.

Radiolabelled medicinal products with lutetium (177Lu) may be administered directly into a vein through a tube called a cannula. Leaks of fluid into the surrounding tissue (extravasation) have been reported. Talk to your doctor if you experience swelling or pain in the arm.

After neuroendocrine tumours are treated with lutetium (177Lu), patients may experience symptoms associated with the release of hormones from tumour cells, known as a carcinoid crisis. Inform your doctor if you feel dizzy or weak or experience flushing or diarrhoea after treatment.

Treatment with lutetium (177Lu) may cause tumour lysis syndrome, due to the rapid destruction of tumour cells. This may cause abnormal blood test results, irregular heartbeats, kidney failure or seizures within a week after treatment. Your doctor will perform blood tests to monitor for this syndrome. Inform your doctor if you experience muscle cramps, muscle weakness, confusion or difficulty breathing.

Refer to the package leaflet of the medicinal product that will be radiolabelled with EndolucinBeta for additional warnings and precautions.

Children and Adolescents

EndolucinBeta must not be used directly in children and adolescents under 18 years of age.

Other Medicinal Products and Radiolabelled Medicinal Products with EndolucinBetaInform your nuclear medicine doctor if you are taking, have recently taken or might take

any other medicinal product, as some medicinal products may interfere with the interpretation of images.

It is not known if lutetium chloride (177Lu) can interact with other medicinal products, as specific studies have not been performed.

Pregnancy and Breast-feeding

You must inform your nuclear medicine doctor before administration of radiolabelled medicinal products with EndolucinBeta if there is any possibility that you may be pregnant, if you have a delayed period or if you are breast-feeding.

In case of doubt, it is important that you consult your nuclear medicine doctor who is supervising the procedure. If you are pregnant

Radiolabelled medicinal products with EndolucinBeta must not be administered if you are pregnant.

If you are breast-feeding

You will be asked to stop breast-feeding.

Please consult your nuclear medicine doctor when you can restart breast-feeding.

Driving and Using Machines

Your ability to drive and use machines may be affected by the medicinal product used in combination with EndolucinBeta. Please read the package leaflet of the medicinal product in question carefully.

3. How to use the Radiolabelled Medicinal Product with EndolucinBeta

There are strict rules for the use, handling and disposal of radiopharmaceuticals. Radiolabelled medicinal products with EndolucinBeta will be used in special controlled areas. This product will only be handled and administered by trained and qualified personnel who are authorized to use it safely. These people will take special care in the safe use of this product and will inform you of their actions.

The nuclear medicine doctor supervising the procedure will decide the amount of radiolabelled medicinal product with EndolucinBeta to be used in your case. This will be the minimum amount necessary to achieve the desired effect, depending on the medicinal product taken with EndolucinBeta and its intended use.

Administration of the Radiolabelled Medicinal Product with EndolucinBeta and Performance of the Procedure

EndolucinBeta must only be used in combination with another medicinal product (carrier medicinal product) that has been specifically developed and authorized for combination with lutetium chloride (177Lu).

Administration will depend on the type of carrier medicinal product. Please read the package leaflet of that medicinal product carefully.

Duration of the Procedure

Your nuclear medicine doctor will inform you about the usual duration of the procedure.

After Administration of the Radiolabelled Medicinal Product with EndolucinBeta, you should

Your nuclear medicine doctor will inform you if you need to take special precautions after administration of the radiolabelled medicinal product with EndolucinBeta. Consult your nuclear medicine doctor if you have any doubts.

If you have been given too much Radiolabelled Medicinal Product with EndolucinBeta

The nuclear medicine doctor will handle the radiolabelled medicinal product with EndolucinBeta under strictly controlled conditions, so it is very unlikely that an overdose will occur. However, in case of overdose or accidental intravenous injection of the unlabelled product, you will receive appropriate treatment that will remove the radionuclide from the body.

If you have any further questions about the use of the radiolabelled medicinal product with EndolucinBeta, consult your nuclear medicine doctor who is supervising the procedure.

.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

As with all medicinal products, the radiolabelled medicinal product with EndolucinBeta may cause side effects, although not everybody gets them.

Dry mouth has been reported in patients with prostate cancer who received treatment with lutetium (177Lu) and this side effect has been transient.

Very common side effects (may affect more than 1 in 10 people):

  • Reduced blood cell count (platelets, red or white blood cells)
  • Nausea
  • Vomiting

Side Effects Reported in Patients Treated for Neuroendocrine Tumours:

Very common (may affect more than 1 in 10 people):

  • Mild and temporary hair loss

Common (may affect up to 1 in 10 people):

  • Bone marrow cancer (myelodysplastic syndrome)
  • Reduced white blood cell count (neutropenia)

Uncommon (may affect up to 1 in 100 people):

  • Bone marrow cancer (acute myeloid leukaemia)

Frequency not known (cannot be estimated from the available data):

  • Carcinoid crisis
  • Tumour lysis syndrome (rapid destruction of tumour cells)
  • Reduced red blood cell, platelet and white blood cell count (pancytopenia)
  • Dry mouth

Cases of bone marrow cancer (myelodysplastic syndrome and acute myeloid leukaemia) have been reported in patients several years after treatment with peptide receptor radionuclide therapy of neuroendocrine tumours labelled with lutetium (177Lu).

After administration of the radiolabelled medicinal product with EndolucinBeta, you will release a certain amount of ionizing radiation (radioactivity) which carries a risk of cancer and genetic defects. In all cases, the radiation risk is outweighed by the potential benefits of administration of the radiolabelled medicinal product.

If you require further information, refer to the package leaflet of the specific medicinal product that will be radiolabelled.

Reporting of Side Effects

If you experience side effects, consult your nuclear medicine doctor, even if they are possible side effects not listed in this leaflet. You can also report them directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicinal product.

5. Storage of EndolucinBeta

You will not need to store this medicinal product. The medicinal product is stored under the responsibility of the specialist in suitable facilities. The storage of radiopharmaceuticals will be carried out in accordance with national regulations on radioactive materials.

The following information is intended for the specialist only.

Keep this medicinal product out of the sight and reach of children.

EndolucinBeta must not be used after the expiry date and time stated on the label after EXP.

EndolucinBeta will be stored in its original packaging which provides protection from radiation.

.

6. Package Contents and Further Information

Composition of EndolucinBeta

  • Its active substance is lutetium chloride (177Lu). 1 ml of sterile solution contains 40 GBq of lutetium chloride (177Lu) at the date and time of calibration (which corresponds to 10 micrograms of lutetium (177Lu) as lutetium chloride (177Lu)). (GBq: Gigabecquerel is the unit in which radioactivity is measured)
  • The other ingredient is hydrochloric acid solution.

Appearance of EndolucinBeta and Package Contents

EndolucinBeta is a radiopharmaceutical precursor in solution. It is presented as a clear and colourless solution in a 2 ml or 10 ml colourless glass vial of type I with a bromobutyl stopper, closed with an aluminium seal.

Each package contains 1 vial, which is placed in a lead container for shielding and packaged in a metal can and outer cardboard box.

The volume of one vial ranges from 0.075-3.75 ml of solution (which corresponds to 3-150 GBq at the date and time of calibration). The volume depends on the amount of medicinal product combined with EndolucinBeta necessary for administration by the nuclear medicine specialist.

Marketing Authorisation Holder and Manufacturer

ITM Medical Isotopes GmbH

Lichtenbergstrasse 1

D-85748 Garching

Germany

Tel: + 49-89-289 139-08

[email protected]

Date of Last Revision of this Leaflet: {Month YYYY}

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

------------------------------------------------------------------------------------------------------------------------

This information is intended for healthcare professionals only:

The full summary of product characteristics of EndolucinBeta is included as a separate document in the product packaging, in order to provide healthcare professionals with additional scientific and practical information on the administration and use of this radiopharmaceutical.

Please refer to this summary of product characteristics.

Online doctors for ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION

Discuss questions about ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
5.0 (26)
Doctor

Giorgi Eremeishvili

Urology 22 years exp.

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

0.0 (13)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations. In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life. Patients consult Dr Daria Portnova for the following concerns: 

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.

Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.

5.0 (71)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

5.0 (52)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
0.0 (14)
Doctor

Antonio Cayatte

General medicine 44 years exp.

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic. His clinical background includes: 

  • assessment of sudden or unclear symptoms
  • ongoing care for chronic conditions
  • follow-up after hospital discharge
  • interpretation of test results
  • medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association. Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Dr. Antonio Cayatte provides comprehensive care for a broad spectrum of common health concerns, including:

  • Respiratory & ENT: acute bronchitis, concerns related to pneumonia, sinusitis, tonsillitis, ear infections, sore throat conditions, and allergic rhinitis
  • Eye Health: allergic and infectious conjunctivitis, as well as red or irritated eyes
  • Digestive & Urinary: gastroesophageal reflux disease (GERD), gastritis, urinary tract infections, and cystitis
  • Chronic Conditions: hypertension, elevated cholesterol, and structured weight management planning
0.0 (0)
Doctor

Maria Martelli

Anaesthesiology 12 years exp.

Dr Maria Martelli is a medical doctor specialising in anaesthesiology and pain medicine. She provides online consultations for adults, focusing on the assessment and management of acute, chronic, and complex pain conditions, as well as supportive care in serious illness. She graduated from the Medical University of Silesia in Katowice and completed her specialisation in Anaesthesiology and Intensive Care. Alongside hospital work, she has extensive experience in home and inpatient hospice care, supporting patients with severe pain and advanced disease. Since 2021, she has been a certified specialist and continues to work in anaesthesiology, intensive care, and pain treatment. Patients consult her for: 

  • Chronic pain lasting more than 3 months (musculoskeletal, neuropathic, mixed pain).
  • Acute pain requiring medical assessment and treatment planning.
  • Post-operative pain and recovery support.
  • Cancer-related pain and symptom relief.
  • Palliative care support and quality-of-life improvement.
  • Adjustment and optimisation of pain medication.
  • Second opinions for complex or treatment-resistant pain.

Dr Martelli takes a structured, evidence-based approach, carefully analysing symptoms, previous treatments, and overall health status. Her consultations focus on realistic pain control goals, safety of therapy, and improving daily functioning. She is especially attentive to patients living with long-term pain or serious illness, providing clear explanations, compassionate guidance, and medically sound recommendations adapted to each individual situation.

3
...

Get ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION?

ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

Who manufactures ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION?

ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION is manufactured by Itm Medical Isotopes Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to ENDOLUCINBETA 40 GBq/mL RADIOFARMACEUTICAL PRECURSOR IN SOLUTION?

Other medicines with the same active substance () include LUTATHERA 370 MBq/mL SOLUTION FOR INFUSION, PLUVICTO 1000 MBq/mL Injectable Solution and Perfusion Solution, Xofigo 1100 kBq/ml injectable solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media